We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Phase I/II Clinical Trial of COVID-19 Vaccine Begins

Product News   May 26, 2020

 
Phase I/II Clinical Trial of COVID-19 Vaccine Begins
FURTHER INFORMATION
 
 
Advertisement
 

Related Product News

Byondis’ Investigational Antibody-Drug Conjugate Selected for Trial in Early-Stage Breast Cancer

Product News

Byondis has announced that Quantum Leap selected the company’s investigational antibody-drug conjugate SYD985 for a new investigational treatment arm in its ongoing I-SPY 2 TRIAL™ for neoadjuvant treatment of locally advanced breast cancer.

READ MORE

Rentschler Biopharma and Vetter Team Up to Optimize Time-To-Market

Product News

Vetter and Rentschler Biopharma have announced their strategic collaboration to enhance their services and offer complementary skills and experience along the biopharmaceutical value chain.

READ MORE

Intravacc to In-license CimCure’s iBoost Technology

Product News

Intravacc has announced the signing of a strategic partnership agreement with Dutch-based CimCure for in-licensing CimCure’s iBoost technology.

READ MORE

Like what you just read? You can find similar content on the communities below.

Biopharma Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE